Prevention of diabetic retinopathy within everyone’s reach.
Prevention of diabetic retinopathy within everyone’s reach
RetinaReadRisk is developing a platform for the early detection and diagnosis of diabetic retinopathy
Mission
Paradigm shift in diabetic retinopathy management
Diabetic retinopathy (DR) is a microvascular complication of type 1 and type 2 diabetes that affects the small vessels of the retina. DR can lead to complete vision loss if not detected early and is the major cause of preventable blindness in working-age adults
Globally, DR is the fifth cause of blindness and visual impairment affecting between 3-4% of people in Europe. DR affects 30% of people with diabetes and it is estimated that 280 million people have lost their sight due to diabetes worldwide.
When detected on time, the risk of DR can be reduced by 95% but the disease is asymptomatic in its early stages and the risk of developing DR varies among patients.
DR can be prevented by controlling risk factors, such as glycemia or arterial hypertension. But existing healthcare systems are inefficient in detecting DR for several reasons as short supply of cameras or the fact that 29% of Europeans live outside urban areas, where ophthalmologist units are not located.
Company Details
- Employees
- 2
- Address
- C/ Baldiri Reixac 4-8, Parc Científic De Barcelona,spain
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- https://retinareadrisk.eu/
- Keywords
- Madrid.
- HQ
- Barcelona, Catalogna
- Competitors
- OFTALVIST, Fundación para la Excelencia y la Calidad de la Oncología (ECO), RETINA-AI Health, Inc., GENESIS Biomed, The Association of Science and Technology Parks of Spain (APTE), ICR Ophthalmology Centre, Fundación para el Conocimiento madri+d, Grupo Peaches Biotech, Retina, Pharma New Talent.
Retina-Read-Risk Questions
Retina-Read-Risk's website is https://retinareadrisk.eu/
Retina-Read-Risk's LinkedIn profile is https://es.linkedin.com/company/retina-read-risk
Retina-Read-Risk has
2 employees.
View email and phone details for 2
employees at Retina-Read-Risk.
Retina-Read-Risk's industry is
Public Health
Retina-Read-Risk's top competitors are
Oftalvist,
Fundación Para La Excelencia Y La Calidad De La Oncología (Eco),
Retina-Ai Health, Inc.,
Genesis Biomed,
The Association Of Science And Technology Parks Of Spain (Apte),
Icr Ophthalmology Centre,
Fundación Para El Conocimiento Madri+d,
Grupo Peaches Biotech,
Retina,
Pharma New Talent.
Retina-Read-Risk's categories are Public Health
